Home/Filings/4/0000950170-25-008014
4//SEC Filing

Scimeca Dario 4

Accession 0000950170-25-008014

CIK 0001357874other

Filed

Jan 21, 7:00 PM ET

Accepted

Jan 22, 9:00 PM ET

Size

13.6 KB

Accession

0000950170-25-008014

Insider Transaction Report

Form 4
Period: 2025-01-20
Scimeca Dario
General Counsel and Secretary
Transactions
  • Exercise/Conversion

    Common Stock

    2025-01-20+25,31233,281 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-01-201,9771,978 total
    Common Stock (1,977 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-01-208,42716,850 total
    Common Stock (8,427 underlying)
  • Sale

    Common Stock

    2025-01-22$4.79/sh8,928$42,76524,353 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-01-2014,90829,815 total
    Common Stock (14,908 underlying)
Footnotes (6)
  • [F1]Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on January 20, 2025.
  • [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F3]The sales were effected pursuant to a Rule 10b5-1 plan adopted on July 14, 2023. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.
  • [F4]On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
  • [F5]On April 18, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
  • [F6]On August 22, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Documents

1 file

Issuer

PRECISION BIOSCIENCES INC

CIK 0001357874

Entity typeother

Related Parties

1
  • filerCIK 0001779581

Filing Metadata

Form type
4
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 9:00 PM ET
Size
13.6 KB